Skip to content

Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women

A Randomized Controlled Trial of Trans Women Connected: a Mobile App Delivered Sexual Health Promotion Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03897049
Acronym
TWC
Enrollment
574
Registered
2019-04-01
Start date
2021-04-01
Completion date
2022-09-07
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Knowledge, Attitudes, Practice, HIV/AIDS, STI

Keywords

Transgender Women, STI, Sexual Health, HIV/AIDS

Brief summary

The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.

Detailed description

A 2-arm cluster randomized controlled trial will be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. The Trans Women Connected intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths-based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP content, post-exposure prophylaxis (PEP) content, and communication forums. To be eligible, participants will be required to self-identify as transgender women; report having had 2 or more sexual partners in the past 90 days with at least one of those partners having a penis; be age 18-49 at baseline; own a smartphone; and reside in any state in the United States. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. Participants will be recruited using a variety of methods, including: 1) Regional transwomen recruitment/retention specialists who are responsible for facilitating recruitment in their regions, addressing study questions, and maintaining connections with each participant to support study engagement; 2) Organizations. Organizations from across the U.S., at least one per state, that serve transgender women will be approached to help recruit participants through social media and in-person. 3) Google Adwords. Placing study advertisements on Google based on keyword for participant recruitment has been shown to be effective. 4) Social Media Advertising including targeted advertising on social media sites (Facebook/Instagram) and sponsoring study posts with social media influencers in the Transwomen community. Social media advertising has been shown to be favorable in terms of its cost-effectiveness, usability, and reach, especially with hard-to-reach populations, young adults and lesbian, gay, bisexual, and transgender (LGBT) populations. 5) Participant Recruitment (participants sharing information about the study within their networks). Participants will complete 4 web-based surveys and will receive $20 for baseline survey, $20 for an immediate posttest, $40 at 3-month follow up, $60 at final 6-month follow up. Randomization. The 2-arm randomized controlled trial involves randomizing individual participants using an equal allocation (allocation ratio 1:1) to receive the full TWC app or an attention control app. Participants were randomized after completing their baseline surveys using the randomizer feature of Qualtrics. Data Collection. Participants will be surveyed at 4 time points. 1) before randomization, 2) after using the mobile app for 1 month, 3) three months after completion of the baseline, and 4) six months after completion of the baseline. Surveys will be completed online through emailed or texted links. Data will also be collected through the apps. This includes usage data, such as what activities participants used and for how long, and process data, which includes content on the communication forum, text answers in the app, and visual content such as vision boards. Participants will receive an incentive of $20 for the baseline and immediate post-intervention survey, $40 for the 3-month follow up survey, and $60 for the 6 month follow up survey. Study Hypotheses. Primary Hypotheses 1 (representing sexual health risk reduction through engagement in care 1) Women in the intervention group will report more STI testing (higher rates of STI testing in the prior 90 days) than the comparison group. Primary Hypotheses 2, women in the intervention group will report fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse. Secondary Hypotheses (representing other important sexual health risk, and psychosocial outcomes):1) Participants in the intervention group will report reduced sexual risk taking including fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse; greater use of condom use at last intercourse (receptive anal or vaginal); and increased use of PrEP for those that are HIV- 2) Participants in the intervention group will engage more with proactive health care and report more health care visits. 3) Participants in the treatment group will report more connectedness with other transgender women, including perceived social support and engagement with a mentor. 4) Participants in the intervention group will report greater efficacy in having safer sex and in communication both with partners and health care workers. 5) Those in the treatment group will have greater acceptance of their gender identity/comfort with gender identity.

Interventions

BEHAVIORALTrans Women Connected

The intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums.

The control group will download a mobile app that addresses COVID and provides COVID resources.

Sponsors

dfusion Inc
CollaboratorINDUSTRY
Portland State University
CollaboratorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
ETR Associates
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

Participants are randomly assigned to their condition without being made aware of their assigned condition. Each condition downloads and uses an app so study activities are similar reducing the likelihood participants will be aware of their assigned condition.

Intervention model description

This is a two arm randomized controlled trial. Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).

Eligibility

Sex/Gender
ALL
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

1. aged 18-49 at the start of the study. 2. self-identify as transgender women 3. self-identify as sexually active with more than one partner in the prior 90 days 4. at least one sexual partner in the last 90 days had a penis 5. has a smartphone 6. resides in the U.S.

Exclusion criteria

Anyone not meeting inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Self-reported HIV or STI Testing in Past 3 Months3-months post interventionParticipant reported having tested for HIV or STI in the past 3 months
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months3-months post interventionParticipant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months

Secondary

MeasureTime frameDescription
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse3-month post interventionParticipant reported using a condom at last receptive anal intercourse or vaginal intercourse
Health Care Visits in Past 3 Months3-months post interventionAverage # of self-reported visits to a health care provider (of any type and by type)
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)1-month post interventionPerceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Transgender Congruence Scale (TCS)1-month post interventionScale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
PrEP Uptake1-month post interventionSelf-reported uptake of PrEP among HIV since last measurement period- subsample
Condom/Barrier Negotiation Self Efficacy Scale1 month post-interventionScale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale1-month post interventionSub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Engaged as/With Mentor in Past 3 Months3-months post interventionSelf-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support
Trans Women Connected Satisfaction Survey1-month post interventionScale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app.

Countries

United States

Participant flow

Participants by arm

ArmCount
TWC App
The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women.
275
General Health App
An alternate mobile app (TWC COVID only) was designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources.
299
Total574

Baseline characteristics

CharacteristicGeneral Health AppTotalTWC App
Age, Continuous31.49 years
STANDARD_DEVIATION 7.88
31.54 years
STANDARD_DEVIATION 7.86
31.59 years
STANDARD_DEVIATION 7.85
Ethnicity (NIH/OMB)
Hispanic or Latino
78 Participants150 Participants72 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
221 Participants423 Participants202 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
HIV test in past 3 months
Not reported
68 Participants131 Participants63 Participants
HIV test in past 3 months
Not tested for HIV in past 3 months
83 Participants158 Participants75 Participants
HIV test in past 3 months
Tested for HIV in past 3 months
148 Participants285 Participants137 Participants
Race (NIH/OMB)
American Indian or Alaska Native
12 Participants19 Participants7 Participants
Race (NIH/OMB)
Asian
13 Participants16 Participants3 Participants
Race (NIH/OMB)
Black or African American
90 Participants166 Participants76 Participants
Race (NIH/OMB)
More than one race
37 Participants76 Participants39 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
8 Participants14 Participants6 Participants
Race (NIH/OMB)
Unknown or Not Reported
22 Participants41 Participants19 Participants
Race (NIH/OMB)
White
117 Participants242 Participants125 Participants
Receptive sex without condom in past 3 months
Did not have receptive sex without a condom in past 3 months
57 Participants116 Participants59 Participants
Receptive sex without condom in past 3 months
Had receptive sex without a condom in past 3 months
232 Participants440 Participants208 Participants
Receptive sex without condom in past 3 months
Not reported
10 Participants18 Participants8 Participants
Region of Enrollment
United States
299 participants574 participants275 participants
Sex/Gender, Customized
Transgender woman
299 participants574 participants275 participants
Sexual orientation
Heterosexual
78 Participants147 Participants69 Participants
Sexual orientation
Not heterosexual
221 Participants427 Participants206 Participants
STI test in past 3 months
Not reported
11 Participants21 Participants10 Participants
STI test in past 3 months
Not tested for STI in past 3 months
108 Participants214 Participants106 Participants
STI test in past 3 months
Tested for STI in past 3 months
180 Participants339 Participants159 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2750 / 299
other
Total, other adverse events
0 / 2750 / 299
serious
Total, serious adverse events
0 / 2750 / 299

Outcome results

Primary

Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months

Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months

Time frame: 6-months post intervention

Population: All participants completing baseline and 6-month follow up survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppReceptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months99 Participants
General Health AppReceptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months96 Participants
p-value: 0.11895% CI: [0.903, 2.466]Regression, Logistic
Primary

Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months

Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months

Time frame: 3-months post intervention

Population: All participants who completed baseline and 3-month follow-up surveys.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppReceptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months106 Participants
General Health AppReceptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months101 Participants
p-value: 0.16795% CI: [0.861, 2.39]Regression, Logistic
Primary

Self-reported HIV or STI Testing in Past 3 Months

Participant reported having tested for HIV or STI in the past 3 months

Time frame: 3-months post intervention

Population: All participants with baseline and 3-month follow-up survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppSelf-reported HIV or STI Testing in Past 3 Months76 Participants
General Health AppSelf-reported HIV or STI Testing in Past 3 Months88 Participants
p-value: 0.91495% CI: [0.463, 1.994]Regression, Logistic
Primary

Self-reported HIV or STI Testing in Past 3 Months

Participant reported having tested for HIV or STI in the past 3 months

Time frame: 6-months post intervention

Population: All participants who completed baseline and 6-month follow-up surveys.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppSelf-reported HIV or STI Testing in Past 3 Months77 Participants
General Health AppSelf-reported HIV or STI Testing in Past 3 Months88 Participants
p-value: 0.9995% CI: [0.473, 2.074]Regression, Logistic
Secondary

Condom/Barrier Negotiation Self Efficacy Scale

Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy

Time frame: 6-month post intervention

Population: Participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppCondom/Barrier Negotiation Self Efficacy Scale5.52 score on a scaleStandard Deviation 1.6
General Health AppCondom/Barrier Negotiation Self Efficacy Scale5.55 score on a scaleStandard Deviation 1.54
p-value: 0.761Regression, Linear
Secondary

Condom/Barrier Negotiation Self Efficacy Scale

Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy

Time frame: 1 month post-intervention

Population: Participants completing baseline and 1-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppCondom/Barrier Negotiation Self Efficacy Scale5.40 score on a scaleStandard Deviation 1.58
General Health AppCondom/Barrier Negotiation Self Efficacy Scale5.48 score on a scaleStandard Deviation 1.59
p-value: 0.65Regression, Linear
Secondary

Condom/Barrier Negotiation Self Efficacy Scale

Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy

Time frame: 3- month post intervention

Population: Participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppCondom/Barrier Negotiation Self Efficacy Scale5.63 score on a scaleStandard Deviation 1.51
General Health AppCondom/Barrier Negotiation Self Efficacy Scale5.54 score on a scaleStandard Deviation 1.49
p-value: 0.531Regression, Linear
Secondary

Engaged as/With Mentor in Past 3 Months

Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support

Time frame: 6-months post intervention

Population: Participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppEngaged as/With Mentor in Past 3 Months6.32 Number of mentor/mentee contactsStandard Deviation 10
General Health AppEngaged as/With Mentor in Past 3 Months3.25 Number of mentor/mentee contactsStandard Deviation 1.55
p-value: 0.218Regression, Linear
Secondary

Engaged as/With Mentor in Past 3 Months

Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support

Time frame: 3-months post intervention

Population: Participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppEngaged as/With Mentor in Past 3 Months5.35 Number of mentee/mentor contactsStandard Deviation 8.53
General Health AppEngaged as/With Mentor in Past 3 Months2.50 Number of mentee/mentor contactsStandard Deviation 1
p-value: 0.189Regression, Linear
Secondary

Health Care Visits in Past 3 Months

Average # of self-reported visits to a health care provider (of any type and by type)

Time frame: 3-months post intervention

Population: All participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppHealth Care Visits in Past 3 Months4.75 Number of visitsStandard Deviation 5.49
General Health AppHealth Care Visits in Past 3 Months5.02 Number of visitsStandard Deviation 4.94
p-value: 0.942Regression, Linear
Secondary

Health Care Visits in Past 3 Months

Average # of self-reported visits to a health care provider (of any type and by type)

Time frame: 6-months post intervention

Population: All participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppHealth Care Visits in Past 3 Months4.63 Number of visitsStandard Deviation 4.54
General Health AppHealth Care Visits in Past 3 Months4.61 Number of visitsStandard Deviation 4.1
p-value: 0.741Regression, Linear
Secondary

Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale

Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services

Time frame: 6- month post intervention

Population: Participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.18 score on a scaleStandard Deviation 0.88
General Health AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.20 score on a scaleStandard Deviation 0.77
p-value: 0.537Regression, Linear
Secondary

Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale

Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services

Time frame: 1-month post intervention

Population: Participants completing baseline and 1-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.14 score on a scaleStandard Deviation 0.86
General Health AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.03 score on a scaleStandard Deviation 0.86
p-value: 0.503Regression, Linear
Secondary

Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale

Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services

Time frame: 3-month post intervention

Population: Participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.17 score on a scaleStandard Deviation 0.88
General Health AppHealth Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale3.16 score on a scaleStandard Deviation 0.8
p-value: 0.541Regression, Linear
Secondary

Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)

Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.

Time frame: 6-month post intervention

Population: All participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.46 score on a scaleStandard Deviation 1.14
General Health AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.16 score on a scaleStandard Deviation 1.09
p-value: 0.022Regression, Linear
Secondary

Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)

Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.

Time frame: 1-month post intervention

Population: All participants completing baseline and 1-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.23 score on a scaleStandard Deviation 1.18
General Health AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.16 score on a scaleStandard Deviation 1.08
p-value: 0.494Regression, Linear
Secondary

Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)

Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.

Time frame: 3-month post intervention

Population: All participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.30 score on a scaleStandard Deviation 1.15
General Health AppMini-Medical Outcomes Study--Social Support Survey (mMOS-SS)3.15 score on a scaleStandard Deviation 1.16
p-value: 0.651Regression, Linear
Secondary

PrEP Uptake

Self-reported uptake of PrEP among HIV since last measurement period- subsample

Time frame: 1-month post intervention

Population: Participants completing baseline and 1-month follow-up survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppPrEP Uptake6 Participants
General Health AppPrEP Uptake13 Participants
p-value: 0.14995% CI: [0.173, 1.305]Regression, Logistic
Secondary

PrEP Uptake

Self-reported uptake of PrEP among HIV since last measurement period- subsample

Time frame: 6-month post intervention

Population: Participants completing baseline and 6-month follow-up survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppPrEP Uptake8 Participants
General Health AppPrEP Uptake4 Participants
p-value: 0.06395% CI: [0.937, 11.641]Regression, Logistic
Secondary

PrEP Uptake

Self-reported uptake of PrEP among HIV since last measurement period- subsample

Time frame: 3-month post intervention

Population: Participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppPrEP Uptake8 Participants
General Health AppPrEP Uptake8 Participants
p-value: 0.83995% CI: [0.403, 3.063]Regression, Logistic
Secondary

Transgender Congruence Scale (TCS)

Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity

Time frame: 6-month post intervention

Population: Participants completing baseline and 6-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppTransgender Congruence Scale (TCS)3.66 score on a scaleStandard Deviation 0.9
General Health AppTransgender Congruence Scale (TCS)3.51 score on a scaleStandard Deviation 0.92
p-value: 0.308Regression, Linear
Secondary

Transgender Congruence Scale (TCS)

Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity

Time frame: 1-month post intervention

Population: Participants completing baseline and 1-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppTransgender Congruence Scale (TCS)3.65 score on a scaleStandard Deviation 0.94
General Health AppTransgender Congruence Scale (TCS)3.46 score on a scaleStandard Deviation 0.91
p-value: 0.057Regression, Linear
Secondary

Transgender Congruence Scale (TCS)

Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity

Time frame: 3-month post intervention

Population: Participants completing baseline and 3-month follow-up surveys.

ArmMeasureValue (MEAN)Dispersion
TWC AppTransgender Congruence Scale (TCS)3.61 score on a scaleStandard Deviation 0.93
General Health AppTransgender Congruence Scale (TCS)3.51 score on a scaleStandard Deviation 0.95
p-value: 0.402Regression, Linear
Secondary

Trans Women Connected Satisfaction Survey

Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app.

Time frame: 1-month post intervention

Population: Participants completing 1-month follow-up survey.

ArmMeasureValue (MEAN)Dispersion
TWC AppTrans Women Connected Satisfaction Survey4.06 score on a scaleStandard Deviation 0.96
General Health AppTrans Women Connected Satisfaction Survey3.58 score on a scaleStandard Deviation 1.2
p-value: 0.001Regression, Linear
Secondary

Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse

Participant reported using a condom at last receptive anal intercourse or vaginal intercourse

Time frame: 3-month post intervention

Population: All participants who completed baseline and 3-month follow-up surveys.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppUse of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse55 Participants
General Health AppUse of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse51 Participants
p-value: 0.26595% CI: [0.803, 2.221]Regression, Logistic
Secondary

Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse

Participant reported using a condom at last receptive anal intercourse or vaginal intercourse

Time frame: 6-month post intervention

Population: All participants who completed baseline and 6-month follow-up surveys.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
TWC AppUse of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse48 Participants
General Health AppUse of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse52 Participants
p-value: 0.97195% CI: [0.593, 1.654]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026